Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-definition/index.php?title=special:booksources&isbn=0865427372) was not found.

Search biology definition index php?title=special:booksources&isbn=0865427372 at Google

Search biology definition index php?title=special:booksources&isbn=0865427372 at Yahoo

Search biology definition index php?title=special:booksources&isbn=0865427372 at Msn

Google
 
(Date:12/4/2009)... University of Iowa investigators have shown how activation of ... the electrical activity of heart cells. , ... online Dec. 3 in the journal PLoS Computational ... interest in calmodulin kinase II as a critical regulator ...
(Date:12/3/2009)... ability to learn new information and adapt to changes in ... appears to lie in the minute junctions where nerve cells ... Center researchers. The study is published online this week in ... by Wen-Biao Gan, PhD, associate professor of physiology and neuroscience ...
(Date:12/3/2009)... year, the CTRC-AACR San Antonio Breast Cancer Symposium continues ... world leaders from industry and academia with the goal ... than 8,500 scientists and other professionals will gather at ... from Dec. 9-13, 2009. The symposium is a partnership ...
Breaking Biology News(10 mins):U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Senior Citizens Bureau Creates New Resourceful Divisions 48034 1Senior Citizens Bureau Creates New Resourceful Divisions 48034 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 1As Biking Popularity Grows so Must the Spotlight on Safety 48031 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 3Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 48027 1Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 48027 2
(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...
(Date:12/6/2009)... Treatment site www.sleeping-with-a-sleeping-disorder.com is asking people ... natural sleep aids from around the world to ... cause. The submissions will be compiled in an ... YOU, to be sold from the website in ... of the proceeds ,from sales of the E-book ...
(Date:12/5/2009)... NEW ORLEANSA new three-drug combination has shown in a ... "highly effective regimen" in the treatment of patients newly ... cells in bone marrow, say researchers from Dana-Farber Cancer ... all of the 66 patients treated with the drug ... a "very good partial response rate" in the phase ...
(Date:12/5/2009)... The first Football,for Hope Centre in Khayelitsha in ... (5 December 2009). FIFA President Joseph S. Blatter ... FIFA World Cup Organising Committee,South Africa (OC) CEO ... and Executive Mayor of the City of Cape ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Biology Products:
... EpochXP Workstations provide comprehensive neurological monitoring ... care unit to accurately access your ... over 15 years experience, and a ... EpochXP neurological monitoring systems have a ...
... powerful, multi-modality system capable of performing EP (including ... and train of four testing tests simultaneously. The ... The base weighs only 4.25 lbs. A complete ... desktop PC-based system with a custom cart can ...
... neuromonitoring system especially designed for surgical monitoring ... 16 channels and is equipped with two ... channel can be independently configured as either ... channel. Endeavor amplifiers are based on the ...
... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...
Medicine Products:
(Date:12/4/2009)... Therapeutics, Inc. today announced that data from pre-clinical studies of ... in vitro and animal models of human chronic myeloid ... upcoming 51st Annual Meeting of the American Society of Hematology ... 2009. The poster will be presented by Stemline,s collaborators at ...
(Date:12/3/2009)... SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... last patient visit in its Phase 2 FDG-PET clinical ... 52 patients and was carried out at five sites ...
(Date:12/3/2009)... /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science ... ), spoke at a conference on High-Risk ... 2009. Beike is China,s leading,stem cell research and ... The conference, organized by the Indian Podiatry Association ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Drug Discovery Technologies - A Global ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery ... of every pharmaceutical company,s business strategy. There ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...
(Date:12/3/2009)... a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... Allen Amatech(TM) OEM (Original Equipment Manufacturer) business website ... the Allen Amatech(TM) brand identity and includes an online ... and design specifications for the products. "We hope to ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 1Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 1Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 3Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 4